Associations between benign cutaneous nevi and risk of Type 2 diabetes mellitus in men and women: results from two prospective cohort studies

H. Dai, Q. Sun, C. Zhang, X. Zhang, W. Q. Li, J. E. Manson, F. B. Hu, Yiqing Song

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Aim: To examine the association of cutaneous nevi with Type 2 diabetes risk. Methods: We prospectivly examined the associations between nevus count and risk of Type 2 diabetes among 26 240 men (1988–2010) from the Health Professionals Follow-up Study and 67 050 women (1986–2010) from the Nurses' Health Study. Information on the numbers of cutaneous nevi on arms at baseline and incident cases of Type 2 diabetes was collected using validated questionnaires. Results: During 1 879 287 person-years of follow-up, we documented 9040 incident cases of Type 2 diabetes. After adjustment for age, BMI and other diabetes risk factors, greater number of nevi was associated with higher risk of Type 2 diabetes. Multivariable-adjusted hazard ratios for <1, 1–5, 6–14 and ≥15 nevi were 1.00 (reference), 1.02 (95% CI 0.93, 1.13), 1.08 (95% CI 0.88, 1.34) and 1.57 (95% CI 1.15, 2.15), respectively, for men (P for linear trend = 0.01), and 1.00 (reference), 1.07 (95% CI 1.02, 1.13), 0.98 (95% CI 0.87, 1.10), and 1.25 (1.01, 1.54), respectively, for women (P for linear trend = 0.05). This positive association remained consistent across subgroups stratified by age, BMI, multivitamin use, smoking status, alcohol, physical activity, history of hypercholesterolaemia, family history of diabetes, history of hypertension and menopausal status (in women). Conclusions: Cutaneous nevus count may represent a novel marker for development of Type 2 diabetes, suggesting a possible unique melanocytic nevus-related mechanism in the pathogenesis of Type 2 diabetes. Further studies are warranted to confirm the findings and to investigate the underlying mechanisms.

Original languageEnglish (US)
Pages (from-to)925-933
Number of pages9
JournalDiabetic Medicine
Volume34
Issue number7
DOIs
StatePublished - Jul 1 2017

Fingerprint

Nevus
Type 2 Diabetes Mellitus
Cohort Studies
Prospective Studies
Skin
Men's Health
Pigmented Nevus
Women's Rights
Hypercholesterolemia
Smoking
Nurses
Alcohols
Exercise
Hypertension
Health

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Associations between benign cutaneous nevi and risk of Type 2 diabetes mellitus in men and women : results from two prospective cohort studies. / Dai, H.; Sun, Q.; Zhang, C.; Zhang, X.; Li, W. Q.; Manson, J. E.; Hu, F. B.; Song, Yiqing.

In: Diabetic Medicine, Vol. 34, No. 7, 01.07.2017, p. 925-933.

Research output: Contribution to journalArticle

Dai, H. ; Sun, Q. ; Zhang, C. ; Zhang, X. ; Li, W. Q. ; Manson, J. E. ; Hu, F. B. ; Song, Yiqing. / Associations between benign cutaneous nevi and risk of Type 2 diabetes mellitus in men and women : results from two prospective cohort studies. In: Diabetic Medicine. 2017 ; Vol. 34, No. 7. pp. 925-933.
@article{0ea3d454c3144278815de903305a2245,
title = "Associations between benign cutaneous nevi and risk of Type 2 diabetes mellitus in men and women: results from two prospective cohort studies",
abstract = "Aim: To examine the association of cutaneous nevi with Type 2 diabetes risk. Methods: We prospectivly examined the associations between nevus count and risk of Type 2 diabetes among 26 240 men (1988–2010) from the Health Professionals Follow-up Study and 67 050 women (1986–2010) from the Nurses' Health Study. Information on the numbers of cutaneous nevi on arms at baseline and incident cases of Type 2 diabetes was collected using validated questionnaires. Results: During 1 879 287 person-years of follow-up, we documented 9040 incident cases of Type 2 diabetes. After adjustment for age, BMI and other diabetes risk factors, greater number of nevi was associated with higher risk of Type 2 diabetes. Multivariable-adjusted hazard ratios for <1, 1–5, 6–14 and ≥15 nevi were 1.00 (reference), 1.02 (95{\%} CI 0.93, 1.13), 1.08 (95{\%} CI 0.88, 1.34) and 1.57 (95{\%} CI 1.15, 2.15), respectively, for men (P for linear trend = 0.01), and 1.00 (reference), 1.07 (95{\%} CI 1.02, 1.13), 0.98 (95{\%} CI 0.87, 1.10), and 1.25 (1.01, 1.54), respectively, for women (P for linear trend = 0.05). This positive association remained consistent across subgroups stratified by age, BMI, multivitamin use, smoking status, alcohol, physical activity, history of hypercholesterolaemia, family history of diabetes, history of hypertension and menopausal status (in women). Conclusions: Cutaneous nevus count may represent a novel marker for development of Type 2 diabetes, suggesting a possible unique melanocytic nevus-related mechanism in the pathogenesis of Type 2 diabetes. Further studies are warranted to confirm the findings and to investigate the underlying mechanisms.",
author = "H. Dai and Q. Sun and C. Zhang and X. Zhang and Li, {W. Q.} and Manson, {J. E.} and Hu, {F. B.} and Yiqing Song",
year = "2017",
month = "7",
day = "1",
doi = "10.1111/dme.13297",
language = "English (US)",
volume = "34",
pages = "925--933",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Associations between benign cutaneous nevi and risk of Type 2 diabetes mellitus in men and women

T2 - results from two prospective cohort studies

AU - Dai, H.

AU - Sun, Q.

AU - Zhang, C.

AU - Zhang, X.

AU - Li, W. Q.

AU - Manson, J. E.

AU - Hu, F. B.

AU - Song, Yiqing

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Aim: To examine the association of cutaneous nevi with Type 2 diabetes risk. Methods: We prospectivly examined the associations between nevus count and risk of Type 2 diabetes among 26 240 men (1988–2010) from the Health Professionals Follow-up Study and 67 050 women (1986–2010) from the Nurses' Health Study. Information on the numbers of cutaneous nevi on arms at baseline and incident cases of Type 2 diabetes was collected using validated questionnaires. Results: During 1 879 287 person-years of follow-up, we documented 9040 incident cases of Type 2 diabetes. After adjustment for age, BMI and other diabetes risk factors, greater number of nevi was associated with higher risk of Type 2 diabetes. Multivariable-adjusted hazard ratios for <1, 1–5, 6–14 and ≥15 nevi were 1.00 (reference), 1.02 (95% CI 0.93, 1.13), 1.08 (95% CI 0.88, 1.34) and 1.57 (95% CI 1.15, 2.15), respectively, for men (P for linear trend = 0.01), and 1.00 (reference), 1.07 (95% CI 1.02, 1.13), 0.98 (95% CI 0.87, 1.10), and 1.25 (1.01, 1.54), respectively, for women (P for linear trend = 0.05). This positive association remained consistent across subgroups stratified by age, BMI, multivitamin use, smoking status, alcohol, physical activity, history of hypercholesterolaemia, family history of diabetes, history of hypertension and menopausal status (in women). Conclusions: Cutaneous nevus count may represent a novel marker for development of Type 2 diabetes, suggesting a possible unique melanocytic nevus-related mechanism in the pathogenesis of Type 2 diabetes. Further studies are warranted to confirm the findings and to investigate the underlying mechanisms.

AB - Aim: To examine the association of cutaneous nevi with Type 2 diabetes risk. Methods: We prospectivly examined the associations between nevus count and risk of Type 2 diabetes among 26 240 men (1988–2010) from the Health Professionals Follow-up Study and 67 050 women (1986–2010) from the Nurses' Health Study. Information on the numbers of cutaneous nevi on arms at baseline and incident cases of Type 2 diabetes was collected using validated questionnaires. Results: During 1 879 287 person-years of follow-up, we documented 9040 incident cases of Type 2 diabetes. After adjustment for age, BMI and other diabetes risk factors, greater number of nevi was associated with higher risk of Type 2 diabetes. Multivariable-adjusted hazard ratios for <1, 1–5, 6–14 and ≥15 nevi were 1.00 (reference), 1.02 (95% CI 0.93, 1.13), 1.08 (95% CI 0.88, 1.34) and 1.57 (95% CI 1.15, 2.15), respectively, for men (P for linear trend = 0.01), and 1.00 (reference), 1.07 (95% CI 1.02, 1.13), 0.98 (95% CI 0.87, 1.10), and 1.25 (1.01, 1.54), respectively, for women (P for linear trend = 0.05). This positive association remained consistent across subgroups stratified by age, BMI, multivitamin use, smoking status, alcohol, physical activity, history of hypercholesterolaemia, family history of diabetes, history of hypertension and menopausal status (in women). Conclusions: Cutaneous nevus count may represent a novel marker for development of Type 2 diabetes, suggesting a possible unique melanocytic nevus-related mechanism in the pathogenesis of Type 2 diabetes. Further studies are warranted to confirm the findings and to investigate the underlying mechanisms.

UR - http://www.scopus.com/inward/record.url?scp=85007448251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007448251&partnerID=8YFLogxK

U2 - 10.1111/dme.13297

DO - 10.1111/dme.13297

M3 - Article

C2 - 27917515

AN - SCOPUS:85007448251

VL - 34

SP - 925

EP - 933

JO - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

IS - 7

ER -